Atara Biotherapeutics Inc
Change company Symbol lookup
Select an option...
ATRA Atara Biotherapeutics Inc
PBA Pembina Pipeline Corp
ZTS Zoetis Inc
HMPT Home Point Capital Inc
KWR Quaker Chemical Corp
TWO Two Harbors Investment Corp
BV Brightview Holdings Inc
PBPB Potbelly Corp
RLJ RLJ Lodging Trust
LHCG LHC Group Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for patients with severe and life-threatening diseases. The Company operates through the business of developing and commercializing therapeutics segment. The Company is focused on developing allogeneic or third-party derived antigen-specific T-cells. T-cells are a type of white blood cell. The Company's product candidate, ATA129, is a third-party derived Epstein-Barr virus CTL for the treatment of Epstein-Barr virus (EBV). ATA188 is in development for the treatment of multiple sclerosis. ATA520, which is a third-party donor derived WT1-CTL, targets cancers expressing the antigen Wilms Tumor 1 (WT1). ATA520 is in Phase I clinical trials. The Company's T-cell product candidate, ATA230, which is a third-party derived cytomegalovirus-CTL (CMV-CTL), is in Phase II clinical trials for refractory CMV.

Closing Price
$12.89
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
917,774
0
  • Prev Close
    12.89
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    917.8K
  • Last (time)
    3:59p ET 05/06/21
  • Last (size)
    5.7K
  • 52-Wk Range
    8.39 - 28.20
    LowHigh
  • (05/06/20 - 12/07/20)
    53.64%
  • 72.2%
  • Market Cap
    1.1B
  • Shares Outstanding
    84.1M
  • -3.86
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.4
  • 95.75
  • (% of float 04/15/21)
    15.02

Latest News

May 04, 2021
4:01 pm ET
BusinessWire
2:33 pm ET
Accesswire
April 27, 2021
5:51 pm ET
BusinessWire
April 02, 2021
4:35 pm ET
BusinessWire
March 14, 2021
4:00 pm ET
BusinessWire
March 09, 2021
4:01 pm ET
BusinessWire
March 05, 2021
4:01 pm ET
BusinessWire
March 01, 2021
4:05 pm ET
BusinessWire
2:30 pm ET
Accesswire
February 18, 2021
4:01 pm ET
BusinessWire
February 08, 2021
9:00 am ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.